Correlation Between Relmada Therapeutics and Aecom Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Relmada Therapeutics and Aecom Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relmada Therapeutics and Aecom Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Relmada Therapeutics and Aecom Technology, you can compare the effects of market volatilities on Relmada Therapeutics and Aecom Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relmada Therapeutics with a short position of Aecom Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relmada Therapeutics and Aecom Technology.

Diversification Opportunities for Relmada Therapeutics and Aecom Technology

-0.16
  Correlation Coefficient

Good diversification

The 3 months correlation between Relmada and Aecom is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Relmada Therapeutics and Aecom Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aecom Technology and Relmada Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relmada Therapeutics are associated (or correlated) with Aecom Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aecom Technology has no effect on the direction of Relmada Therapeutics i.e., Relmada Therapeutics and Aecom Technology go up and down completely randomly.

Pair Corralation between Relmada Therapeutics and Aecom Technology

Given the investment horizon of 90 days Relmada Therapeutics is expected to under-perform the Aecom Technology. In addition to that, Relmada Therapeutics is 4.96 times more volatile than Aecom Technology. It trades about -0.14 of its total potential returns per unit of risk. Aecom Technology is currently generating about 0.08 per unit of volatility. If you would invest  8,953  in Aecom Technology on January 24, 2024 and sell it today you would earn a total of  312.00  from holding Aecom Technology or generate 3.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Relmada Therapeutics  vs.  Aecom Technology

 Performance 
       Timeline  
Relmada Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Relmada Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, Relmada Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Aecom Technology 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Aecom Technology are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy fundamental indicators, Aecom Technology is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Relmada Therapeutics and Aecom Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Relmada Therapeutics and Aecom Technology

The main advantage of trading using opposite Relmada Therapeutics and Aecom Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relmada Therapeutics position performs unexpectedly, Aecom Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aecom Technology will offset losses from the drop in Aecom Technology's long position.
The idea behind Relmada Therapeutics and Aecom Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets